Mer­ck KGaA shuf­fles or­ga­ni­za­tion to boost its CD­MO op­er­a­tion as a top ex­ec re­tires

Mer­ck KGaA is re­or­ga­niz­ing af­ter a key sup­ply chain ex­ec­u­tive’s re­tire­ment, build­ing out a new life sci­ence unit with a ful­ly in­te­grat­ed CD­MO and con­tract test­ing ser­vice busi­ness.

In Burling­ton, MA, about 15 miles north­west of down­town Boston, the new life sci­ences ser­vices unit (LSS for short) will com­bine the ex­ist­ing CD­MO and con­tract test­ing units, along with the re­spec­tive mar­ket­ing, sales, re­search and de­vel­op­ment, man­u­fac­tur­ing and sup­ply chain op­er­a­tions. Every­thing from mon­o­clon­al an­ti­bod­ies to high po­ten­cy APIs, AD­Cs and vi­ral and gene ther­a­pies will be housed in­side LSS. It will al­so in­clude the com­pa­ny’s mR­NA op­er­a­tions, which have re­cent­ly been boost­ed with ac­qui­si­tions of AmpTec in 2021 and Ex­e­lead, which was an­nounced last month.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER